Key facts
- It has raised $523.5M across 1 recorded rounds; the latest was Early Stage VC ($30.0M) in Mar 2021.
- Notable investors include Samsung NEXT Ventures, Samsung Venture Investment, Canaan Partners, Social Capital, Georgian — 15 tracked in total.
- Glooko has filed 3 Form Ds with the SEC since 2021, most recently Aug 2024 ( sold).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Glooko
Funding rounds
1 roundsAbout Glooko
Developer of a remote patient-monitoring platform intended to identify at-risk patients and provide quality-enhancing interventions. The company's platform synchronizes with diabetes devices, fitness wearables, and activity trackers to enable data capture and provide reports and analytics that aim to drive behavior change and outcomes, enabling healthcare providers to support remote monitoring efforts to improve patient care.
- Sector
- Healthcare
- HQ
- Palo Alto, CA, United States
- Founded
- 2010
- Employees
- 192
- Website
- glooko.com/
- Ownership
- Privately Held (backing)
Glooko doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Glooko shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Glooko in its N-PORT filings yet. We sweep new filings monthly.